SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics - Webinar

Online

Genomics Unlocked

Watch Webinar

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics - Webinar
SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics - Webinar
SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics - Webinar
SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics - Webinar

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

Dive deep into the dynamic world of spatial multi-omics as we explore its revolutionary applications in genomics research. This blog post, inspired by discussions with industry experts, focuses on the latest advancements in spatial transcriptomics and their significant impact on scientific and clinical research.

The Revolutionary Technology of Spatial Enhanced Resolution Omic Sequencing

Spatial enhanced resolution omic sequencing represents a major leap in genomic science. This state-of-the-art technology facilitates an in-depth exploration of biological complexities, revolutionizing how researchers understand the spatial-temporal dimensions of biology.

Key Features and Applications:

  • High Resolution and Accuracy: This technology sets a new standard in spatial transcriptomics, offering unmatched precision. Its capability to detect the smallest nuances in biological samples is unparalleled.

  • Versatility in Sample Types: Its application extends beyond human tissues to plant tissues, making it a versatile asset in various fields of biological research.

  • 3D Reconstruction and Cell Segmentation: Offering 3D reconstruction and detailed cell segmentation analysis, this technology provides critical insights into the spatial organization within cells and tissues.

Integration of Stereoseq and MGI Sequencing Products

The combination of Stereoseq with MGI sequencing technologies, like the G400 and T7 sequencers, marks a significant advancement in spatial omics. This synergy enhances the capabilities of spatial multi-omics research.

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

Dive deep into the dynamic world of spatial multi-omics as we explore its revolutionary applications in genomics research. This blog post, inspired by discussions with industry experts, focuses on the latest advancements in spatial transcriptomics and their significant impact on scientific and clinical research.

The Revolutionary Technology of Spatial Enhanced Resolution Omic Sequencing

Spatial enhanced resolution omic sequencing represents a major leap in genomic science. This state-of-the-art technology facilitates an in-depth exploration of biological complexities, revolutionizing how researchers understand the spatial-temporal dimensions of biology.

Key Features and Applications:

  • High Resolution and Accuracy: This technology sets a new standard in spatial transcriptomics, offering unmatched precision. Its capability to detect the smallest nuances in biological samples is unparalleled.

  • Versatility in Sample Types: Its application extends beyond human tissues to plant tissues, making it a versatile asset in various fields of biological research.

  • 3D Reconstruction and Cell Segmentation: Offering 3D reconstruction and detailed cell segmentation analysis, this technology provides critical insights into the spatial organization within cells and tissues.

Integration of Stereoseq and MGI Sequencing Products

The combination of Stereoseq with MGI sequencing technologies, like the G400 and T7 sequencers, marks a significant advancement in spatial omics. This synergy enhances the capabilities of spatial multi-omics research.

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

Dive deep into the dynamic world of spatial multi-omics as we explore its revolutionary applications in genomics research. This blog post, inspired by discussions with industry experts, focuses on the latest advancements in spatial transcriptomics and their significant impact on scientific and clinical research.

The Revolutionary Technology of Spatial Enhanced Resolution Omic Sequencing

Spatial enhanced resolution omic sequencing represents a major leap in genomic science. This state-of-the-art technology facilitates an in-depth exploration of biological complexities, revolutionizing how researchers understand the spatial-temporal dimensions of biology.

Key Features and Applications:

  • High Resolution and Accuracy: This technology sets a new standard in spatial transcriptomics, offering unmatched precision. Its capability to detect the smallest nuances in biological samples is unparalleled.

  • Versatility in Sample Types: Its application extends beyond human tissues to plant tissues, making it a versatile asset in various fields of biological research.

  • 3D Reconstruction and Cell Segmentation: Offering 3D reconstruction and detailed cell segmentation analysis, this technology provides critical insights into the spatial organization within cells and tissues.

Integration of Stereoseq and MGI Sequencing Products

The combination of Stereoseq with MGI sequencing technologies, like the G400 and T7 sequencers, marks a significant advancement in spatial omics. This synergy enhances the capabilities of spatial multi-omics research.

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

Dive deep into the dynamic world of spatial multi-omics as we explore its revolutionary applications in genomics research. This blog post, inspired by discussions with industry experts, focuses on the latest advancements in spatial transcriptomics and their significant impact on scientific and clinical research.

The Revolutionary Technology of Spatial Enhanced Resolution Omic Sequencing

Spatial enhanced resolution omic sequencing represents a major leap in genomic science. This state-of-the-art technology facilitates an in-depth exploration of biological complexities, revolutionizing how researchers understand the spatial-temporal dimensions of biology.

Key Features and Applications:

  • High Resolution and Accuracy: This technology sets a new standard in spatial transcriptomics, offering unmatched precision. Its capability to detect the smallest nuances in biological samples is unparalleled.

  • Versatility in Sample Types: Its application extends beyond human tissues to plant tissues, making it a versatile asset in various fields of biological research.

  • 3D Reconstruction and Cell Segmentation: Offering 3D reconstruction and detailed cell segmentation analysis, this technology provides critical insights into the spatial organization within cells and tissues.

Integration of Stereoseq and MGI Sequencing Products

The combination of Stereoseq with MGI sequencing technologies, like the G400 and T7 sequencers, marks a significant advancement in spatial omics. This synergy enhances the capabilities of spatial multi-omics research.

MGI's DNBSEQ-T7 is a transformative force in spatial enhanced resolution omic sequencing. Excelling in accuracy and efficiency, it complements Stereoseq's high-resolution capabilities in spatial transcriptomics. Ideal for intricate genomic research, the DNBSEQ-T7 is instrumental in deepening our understanding of biological systems and advancing studies in neurodegenerative diseases like frontotemporal dementia, marking a new era in genomic exploration.

These MGI sequencers, when used in conjunction with Stereoseq, optimize DNA nanoball (DNB) sequencing technology. This integration minimizes amplification errors and index hopping, ensuring high-quality sequencing outcomes.

Advancing Human Protein Research through Spatial Transcriptomics

Spatial transcriptomics is pioneering new methodologies in understanding protein distribution, particularly in brain research. This approach offers a more nuanced view of protein expression, pivotal in the study of complex biological systems.

Breakthroughs in Disease Research:

  • Frontotemporal Dementia Studies: The use of spatial transcriptomics in neurodegenerative disease research, like frontotemporal dementia, showcases its potential in unraveling the complexities of these conditions.

  • Enhanced Data Analysis: This technology's ability to deliver cellular-level visualizations and analyses opens new paths for understanding the mechanisms behind various brain disorders and diseases.

The Impact of MGI Sequencing in Spatial Multi-Omics

MGI's sequencing technology plays a vital role in advancing spatial multi-omics. The G400 and G7 sequencers, in particular, have become instrumental in driving forward genomic and proteomic studies. Their compatibility with spatial transcriptomics tools like Stereoseq enhances the accuracy and detail of research outcomes.

MGI's Role in Spatial Genomics:

  • Innovation in Sequencing Technology: MGI's sequencing solutions, with their precision and efficiency, are at the forefront of genomic research.

  • Enhancing Research Capabilities: The integration of MGI sequencing products with spatial transcriptomics tools broadens the scope of research, facilitating more comprehensive studies in various fields.

Conclusion

The advancements in spatial enhanced resolution omic sequencing, particularly when combined with MGI's sequencing technologies, represent a significant stride in multi-omics research. These developments are not just reshaping our understanding of genomics and proteomics but also paving the way for groundbreaking discoveries in understanding complex biological systems. Spatial transcriptomics, especially in the context of brain research and neurodegenerative diseases, stands at the cusp of revolutionizing our approach to scientific exploration.

Disclaimer: The information provided in this blog is for educational and informational purposes only and is not intended for use in diagnostic procedures. MGI products mentioned are for research use only.

MGI's DNBSEQ-T7 is a transformative force in spatial enhanced resolution omic sequencing. Excelling in accuracy and efficiency, it complements Stereoseq's high-resolution capabilities in spatial transcriptomics. Ideal for intricate genomic research, the DNBSEQ-T7 is instrumental in deepening our understanding of biological systems and advancing studies in neurodegenerative diseases like frontotemporal dementia, marking a new era in genomic exploration.

These MGI sequencers, when used in conjunction with Stereoseq, optimize DNA nanoball (DNB) sequencing technology. This integration minimizes amplification errors and index hopping, ensuring high-quality sequencing outcomes.

Advancing Human Protein Research through Spatial Transcriptomics

Spatial transcriptomics is pioneering new methodologies in understanding protein distribution, particularly in brain research. This approach offers a more nuanced view of protein expression, pivotal in the study of complex biological systems.

Breakthroughs in Disease Research:

  • Frontotemporal Dementia Studies: The use of spatial transcriptomics in neurodegenerative disease research, like frontotemporal dementia, showcases its potential in unraveling the complexities of these conditions.

  • Enhanced Data Analysis: This technology's ability to deliver cellular-level visualizations and analyses opens new paths for understanding the mechanisms behind various brain disorders and diseases.

The Impact of MGI Sequencing in Spatial Multi-Omics

MGI's sequencing technology plays a vital role in advancing spatial multi-omics. The G400 and G7 sequencers, in particular, have become instrumental in driving forward genomic and proteomic studies. Their compatibility with spatial transcriptomics tools like Stereoseq enhances the accuracy and detail of research outcomes.

MGI's Role in Spatial Genomics:

  • Innovation in Sequencing Technology: MGI's sequencing solutions, with their precision and efficiency, are at the forefront of genomic research.

  • Enhancing Research Capabilities: The integration of MGI sequencing products with spatial transcriptomics tools broadens the scope of research, facilitating more comprehensive studies in various fields.

Conclusion

The advancements in spatial enhanced resolution omic sequencing, particularly when combined with MGI's sequencing technologies, represent a significant stride in multi-omics research. These developments are not just reshaping our understanding of genomics and proteomics but also paving the way for groundbreaking discoveries in understanding complex biological systems. Spatial transcriptomics, especially in the context of brain research and neurodegenerative diseases, stands at the cusp of revolutionizing our approach to scientific exploration.

Disclaimer: The information provided in this blog is for educational and informational purposes only and is not intended for use in diagnostic procedures. MGI products mentioned are for research use only.

MGI's DNBSEQ-T7 is a transformative force in spatial enhanced resolution omic sequencing. Excelling in accuracy and efficiency, it complements Stereoseq's high-resolution capabilities in spatial transcriptomics. Ideal for intricate genomic research, the DNBSEQ-T7 is instrumental in deepening our understanding of biological systems and advancing studies in neurodegenerative diseases like frontotemporal dementia, marking a new era in genomic exploration.

These MGI sequencers, when used in conjunction with Stereoseq, optimize DNA nanoball (DNB) sequencing technology. This integration minimizes amplification errors and index hopping, ensuring high-quality sequencing outcomes.

Advancing Human Protein Research through Spatial Transcriptomics

Spatial transcriptomics is pioneering new methodologies in understanding protein distribution, particularly in brain research. This approach offers a more nuanced view of protein expression, pivotal in the study of complex biological systems.

Breakthroughs in Disease Research:

  • Frontotemporal Dementia Studies: The use of spatial transcriptomics in neurodegenerative disease research, like frontotemporal dementia, showcases its potential in unraveling the complexities of these conditions.

  • Enhanced Data Analysis: This technology's ability to deliver cellular-level visualizations and analyses opens new paths for understanding the mechanisms behind various brain disorders and diseases.

The Impact of MGI Sequencing in Spatial Multi-Omics

MGI's sequencing technology plays a vital role in advancing spatial multi-omics. The G400 and G7 sequencers, in particular, have become instrumental in driving forward genomic and proteomic studies. Their compatibility with spatial transcriptomics tools like Stereoseq enhances the accuracy and detail of research outcomes.

MGI's Role in Spatial Genomics:

  • Innovation in Sequencing Technology: MGI's sequencing solutions, with their precision and efficiency, are at the forefront of genomic research.

  • Enhancing Research Capabilities: The integration of MGI sequencing products with spatial transcriptomics tools broadens the scope of research, facilitating more comprehensive studies in various fields.

Conclusion

The advancements in spatial enhanced resolution omic sequencing, particularly when combined with MGI's sequencing technologies, represent a significant stride in multi-omics research. These developments are not just reshaping our understanding of genomics and proteomics but also paving the way for groundbreaking discoveries in understanding complex biological systems. Spatial transcriptomics, especially in the context of brain research and neurodegenerative diseases, stands at the cusp of revolutionizing our approach to scientific exploration.

Disclaimer: The information provided in this blog is for educational and informational purposes only and is not intended for use in diagnostic procedures. MGI products mentioned are for research use only.

MGI's DNBSEQ-T7 is a transformative force in spatial enhanced resolution omic sequencing. Excelling in accuracy and efficiency, it complements Stereoseq's high-resolution capabilities in spatial transcriptomics. Ideal for intricate genomic research, the DNBSEQ-T7 is instrumental in deepening our understanding of biological systems and advancing studies in neurodegenerative diseases like frontotemporal dementia, marking a new era in genomic exploration.

These MGI sequencers, when used in conjunction with Stereoseq, optimize DNA nanoball (DNB) sequencing technology. This integration minimizes amplification errors and index hopping, ensuring high-quality sequencing outcomes.

Advancing Human Protein Research through Spatial Transcriptomics

Spatial transcriptomics is pioneering new methodologies in understanding protein distribution, particularly in brain research. This approach offers a more nuanced view of protein expression, pivotal in the study of complex biological systems.

Breakthroughs in Disease Research:

  • Frontotemporal Dementia Studies: The use of spatial transcriptomics in neurodegenerative disease research, like frontotemporal dementia, showcases its potential in unraveling the complexities of these conditions.

  • Enhanced Data Analysis: This technology's ability to deliver cellular-level visualizations and analyses opens new paths for understanding the mechanisms behind various brain disorders and diseases.

The Impact of MGI Sequencing in Spatial Multi-Omics

MGI's sequencing technology plays a vital role in advancing spatial multi-omics. The G400 and G7 sequencers, in particular, have become instrumental in driving forward genomic and proteomic studies. Their compatibility with spatial transcriptomics tools like Stereoseq enhances the accuracy and detail of research outcomes.

MGI's Role in Spatial Genomics:

  • Innovation in Sequencing Technology: MGI's sequencing solutions, with their precision and efficiency, are at the forefront of genomic research.

  • Enhancing Research Capabilities: The integration of MGI sequencing products with spatial transcriptomics tools broadens the scope of research, facilitating more comprehensive studies in various fields.

Conclusion

The advancements in spatial enhanced resolution omic sequencing, particularly when combined with MGI's sequencing technologies, represent a significant stride in multi-omics research. These developments are not just reshaping our understanding of genomics and proteomics but also paving the way for groundbreaking discoveries in understanding complex biological systems. Spatial transcriptomics, especially in the context of brain research and neurodegenerative diseases, stands at the cusp of revolutionizing our approach to scientific exploration.

Disclaimer: The information provided in this blog is for educational and informational purposes only and is not intended for use in diagnostic procedures. MGI products mentioned are for research use only.

Über MGI

MGI Tech Co., Ltd. (MGI) ist an vorderster Front der globalen Innovation tätig und leistet aktiv einen Beitrag zur Lebenswissenschaft durch intelligente Innovation. Mit Präsenz in über 100 Ländern und einer Kundenbasis von mehr als 2600 hat die hochmoderne Technologie von MGI wesentlich zur Entwicklung von über 736 Benutzerpatenten beigetragen und die Erstellung von über 150 Petabyte an Daten ermöglicht. Das umfangreiche Portfolio des Unternehmens umfasst Sequenziergeräte, Automatisierungsgeräte, Reagenzien und verwandte Produkte, die verschiedene Bereiche wie die Lebenswissenschaftsforschung, Landwirtschaft, Präzisionsmedizin und Gesundheitswesen bedienen.

MGI widmet sich der Weiterentwicklung von Werkzeugen für die Lebenswissenschaften im Hinblick auf das Gesundheitswesen der Zukunft. Bis Dezember 2021 hat die globale Präsenz des Unternehmens auf über 100 Länder und Regionen zugenommen und bedient über 1.300 internationale Kunden. Mit einer Belegschaft von über 2.900 Fachleuten weltweit, einschließlich 5 Zentren für Forschung und Entwicklung sowie Produktionsstätten in Europa, ist MGI darum bemüht, Innovationen zu fördern. Etwa 35% der Mitarbeiter von MGI sind in F&E tätig, was die Ausrichtung des Unternehmens auf wegweisende Fortschritte in diesem Bereich unterstreicht.

Die Auswirkungen der Arbeit von MGI werden durch die Veröffentlichung von über 6.800 Artikeln in angesehenen wissenschaftlichen Fachzeitschriften weiter belegt, was die bedeutende Beitrag der Technologie von MGI zur wissenschaftlichen Gemeinschaft und darüber hinaus zeigt.

Für weitere Informationen über MGI und seine Beiträge zu den Lebenswissenschaften und dem Gesundheitswesen besuchen Sie bitte die MGI-Website oder folgen Sie uns auf Twitter, LinkedIn oder YouTube.

Über MGI

MGI Tech Co., Ltd. (MGI) ist an vorderster Front der globalen Innovation tätig und leistet aktiv einen Beitrag zur Lebenswissenschaft durch intelligente Innovation. Mit Präsenz in über 100 Ländern und einer Kundenbasis von mehr als 2600 hat die hochmoderne Technologie von MGI wesentlich zur Entwicklung von über 736 Benutzerpatenten beigetragen und die Erstellung von über 150 Petabyte an Daten ermöglicht. Das umfangreiche Portfolio des Unternehmens umfasst Sequenziergeräte, Automatisierungsgeräte, Reagenzien und verwandte Produkte, die verschiedene Bereiche wie die Lebenswissenschaftsforschung, Landwirtschaft, Präzisionsmedizin und Gesundheitswesen bedienen.

MGI widmet sich der Weiterentwicklung von Werkzeugen für die Lebenswissenschaften im Hinblick auf das Gesundheitswesen der Zukunft. Bis Dezember 2021 hat die globale Präsenz des Unternehmens auf über 100 Länder und Regionen zugenommen und bedient über 1.300 internationale Kunden. Mit einer Belegschaft von über 2.900 Fachleuten weltweit, einschließlich 5 Zentren für Forschung und Entwicklung sowie Produktionsstätten in Europa, ist MGI darum bemüht, Innovationen zu fördern. Etwa 35% der Mitarbeiter von MGI sind in F&E tätig, was die Ausrichtung des Unternehmens auf wegweisende Fortschritte in diesem Bereich unterstreicht.

Die Auswirkungen der Arbeit von MGI werden durch die Veröffentlichung von über 6.800 Artikeln in angesehenen wissenschaftlichen Fachzeitschriften weiter belegt, was die bedeutende Beitrag der Technologie von MGI zur wissenschaftlichen Gemeinschaft und darüber hinaus zeigt.

Für weitere Informationen über MGI und seine Beiträge zu den Lebenswissenschaften und dem Gesundheitswesen besuchen Sie bitte die MGI-Website oder folgen Sie uns auf Twitter, LinkedIn oder YouTube.

Über MGI

MGI Tech Co., Ltd. (MGI) ist an vorderster Front der globalen Innovation tätig und leistet aktiv einen Beitrag zur Lebenswissenschaft durch intelligente Innovation. Mit Präsenz in über 100 Ländern und einer Kundenbasis von mehr als 2600 hat die hochmoderne Technologie von MGI wesentlich zur Entwicklung von über 736 Benutzerpatenten beigetragen und die Erstellung von über 150 Petabyte an Daten ermöglicht. Das umfangreiche Portfolio des Unternehmens umfasst Sequenziergeräte, Automatisierungsgeräte, Reagenzien und verwandte Produkte, die verschiedene Bereiche wie die Lebenswissenschaftsforschung, Landwirtschaft, Präzisionsmedizin und Gesundheitswesen bedienen.

MGI widmet sich der Weiterentwicklung von Werkzeugen für die Lebenswissenschaften im Hinblick auf das Gesundheitswesen der Zukunft. Bis Dezember 2021 hat die globale Präsenz des Unternehmens auf über 100 Länder und Regionen zugenommen und bedient über 1.300 internationale Kunden. Mit einer Belegschaft von über 2.900 Fachleuten weltweit, einschließlich 5 Zentren für Forschung und Entwicklung sowie Produktionsstätten in Europa, ist MGI darum bemüht, Innovationen zu fördern. Etwa 35% der Mitarbeiter von MGI sind in F&E tätig, was die Ausrichtung des Unternehmens auf wegweisende Fortschritte in diesem Bereich unterstreicht.

Die Auswirkungen der Arbeit von MGI werden durch die Veröffentlichung von über 6.800 Artikeln in angesehenen wissenschaftlichen Fachzeitschriften weiter belegt, was die bedeutende Beitrag der Technologie von MGI zur wissenschaftlichen Gemeinschaft und darüber hinaus zeigt.

Für weitere Informationen über MGI und seine Beiträge zu den Lebenswissenschaften und dem Gesundheitswesen besuchen Sie bitte die MGI-Website oder folgen Sie uns auf Twitter, LinkedIn oder YouTube.

Über MGI

MGI Tech Co., Ltd. (MGI) ist an vorderster Front der globalen Innovation tätig und leistet aktiv einen Beitrag zur Lebenswissenschaft durch intelligente Innovation. Mit Präsenz in über 100 Ländern und einer Kundenbasis von mehr als 2600 hat die hochmoderne Technologie von MGI wesentlich zur Entwicklung von über 736 Benutzerpatenten beigetragen und die Erstellung von über 150 Petabyte an Daten ermöglicht. Das umfangreiche Portfolio des Unternehmens umfasst Sequenziergeräte, Automatisierungsgeräte, Reagenzien und verwandte Produkte, die verschiedene Bereiche wie die Lebenswissenschaftsforschung, Landwirtschaft, Präzisionsmedizin und Gesundheitswesen bedienen.

MGI widmet sich der Weiterentwicklung von Werkzeugen für die Lebenswissenschaften im Hinblick auf das Gesundheitswesen der Zukunft. Bis Dezember 2021 hat die globale Präsenz des Unternehmens auf über 100 Länder und Regionen zugenommen und bedient über 1.300 internationale Kunden. Mit einer Belegschaft von über 2.900 Fachleuten weltweit, einschließlich 5 Zentren für Forschung und Entwicklung sowie Produktionsstätten in Europa, ist MGI darum bemüht, Innovationen zu fördern. Etwa 35% der Mitarbeiter von MGI sind in F&E tätig, was die Ausrichtung des Unternehmens auf wegweisende Fortschritte in diesem Bereich unterstreicht.

Die Auswirkungen der Arbeit von MGI werden durch die Veröffentlichung von über 6.800 Artikeln in angesehenen wissenschaftlichen Fachzeitschriften weiter belegt, was die bedeutende Beitrag der Technologie von MGI zur wissenschaftlichen Gemeinschaft und darüber hinaus zeigt.

Für weitere Informationen über MGI und seine Beiträge zu den Lebenswissenschaften und dem Gesundheitswesen besuchen Sie bitte die MGI-Website oder folgen Sie uns auf Twitter, LinkedIn oder YouTube.

Teilen Sie diesen Artikel :

Mehr Veranstaltungen

Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024

18.03.2024

Join MGI at Spatial Biology UK 2024

Discover Genomic Innovations with MGI at Spatial Biology UK 2024! Join us on March 18th-19th at booth 15 at Novotel London West. Don't miss out!

Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference

27.01.2024

Join us at EACR-AACR-IACR Basic and Translational Research Conference

Join us at booth 5 during the EACR-AACR-IACR Basic and Translational Research Conference with the MGI Team in Dublin, Ireland from February 27-29.

Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January

24.01.2024

Join us at The Festival of Genomics & Biodata in January

Join us at booth 98 with MGI Tech during The Festival of Genomics & Biodata on January 24th-25th, 2024, at ExCeL in London.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.